Rafferty Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
|
|||||
|
2025
Q4 | $226K | Sell |
|
|||||
|
2025
Q3 | $257K | Sell |
|
|||||
|
2025
Q2 | $2.61M | Sell |
|
|||||
|
2025
Q1 | $3.43M | Buy |
|
|||||
|
2024
Q4 | $4.15M | Sell |
|
|||||
|
2024
Q3 | $4.98M | Sell |
|
|||||
|
2024
Q2 | $5.02M | Sell |
|
|||||
|
2024
Q1 | $10.2M | Sell |
|
|||||
|
2023
Q4 | $8.69M | Buy |
|
|||||
|
2023
Q3 | $5.88M | Buy |
|
|||||
|
2023
Q2 | $2.49M | Buy |
|
|||||
|
2023
Q1 | $2.07M | Buy |
|
|||||
|
2022
Q4 | $1.95M | Buy |
|
|||||
|
2022
Q3 | $1.48M | Buy |
|
|||||
|
2022
Q2 | $835K | Sell |
|
|||||
|
2022
Q1 | $1.72M | Buy |
|
|||||
|
2021
Q4 | $1.48M | Buy |
|
|||||
|
2021
Q3 | $579K | Buy |
|